AzTrials
AzTrials

Research institution

Massachusetts General Hospital Clinical Trials

Studies where Massachusetts General Hospital is the lead sponsor: what is enrolling now, by phase, condition and country.

2,582 registered studies

In numbers

Open to volunteers
440
Active
591
With results posted
831
All registered
2,582

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 440
  • Borderline Personality Disorder (BPD)

    Combining Transcranial Magnetic Stimulation With Emotion Regulation Skills Training in Borderline Personality Disorder

    • Recruiting
    • Age: 22 to 65 years
    • Medical device
    • Lifestyle or therapy programme

    Impaired emotion regulation is a core feature of borderline personality disorder (BPD) and a known driver of functional impairment, interpersonal difficulties, self-harm, and suicidality.

    Trial name
    NCT07714005
    Testing
    Transcranial Magnetic Stimulation (TMS), Emotion Regulation Skills Training
    Where
    United States
    Volunteers
    12 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? NCT07714005
  • Lymphoma

    A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

    • Recruiting
    • Age: 18 years and older

    The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.

    Trial name
    NCT07013435
    Testing
    Health Education Program, SMART3RP-Lymphoma
    Where
    3 sites in United States
    Volunteers
    254 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? NCT07013435
  • Avoidant/Restrictive Food Intake Disorder (ARFID)

    Cognitive-behavioral Therapy vs. Nutrition Counseling for Avoidant/Restrictive Food Intake Disorder Part II

    • Recruiting
    • Age: 10 to 18 years
    • Lifestyle or therapy programme

    This study is a randomized controlled trial assessing the efficacy of cognitive- behavioral therapy (CBT-AR) and nutrition counseling for avoidant/restrictive food intake disorder (ARFID) for children and adolescents (ages 10-18…

    Trial name
    COUNTERACT-2 (NCT07641205)
    Testing
    Cognitive-Behavioral Therapy for Avoidance Restrictive Food Intake Disorder (CBT-AR), Nutrition Counseling for Avoidant/Restrictive Food Intake Disorder
    Where
    United States
    Volunteers
    70 people
    Sponsor
    Massachusetts General Hospital
  • Arginine Vasopressin Deficiency, Oxytocin Deficiency

    Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

    • Recruiting
    • Age: 7 to 21 years
    • Early Phase 1

    An open-labeled, interventional pilot trial, 10 youth with AVP-D and 10 PD matched for age, sex, and BMI will be recruited from Pediatric Endocrinology and Neuroendocrinology at Massachusetts General Hospital and in the…

    Conditions
    Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism
    Trial name
    Pedi-EVOLVE (NCT07568509)
    Testing
    Norethindrone Acetate-Ethinyl Estradiol
    Where
    United States
    Volunteers
    20 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? Pedi-EVOLVE
  • Uveal Melanoma

    Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

    • Recruiting
    • Age: 18 years and older

    This study seeks to better understand the liver's immune response to receiving chemotherapy agent melphalan through Percutaneous Hepatic Perfusion (PHP) alone or in combination with Ipilimumab and Nivolumab for patients with…

    Trial name
    NCT07364474
    Testing
    Melphalan through Percutaneous Hepatic Perfusion, Melphalan through Percutaneous Hepatic Perfusion in combination with Ipilimumab and Nivolumab
    Where
    United States
    Volunteers
    20 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? NCT07364474
  • Chimeric Antigen Receptor T-cell Therapy, Hematologic Malignancy

    Symptom Monitoring and Management Intervention After CAR-T

    • Not yet recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    The goal of this study is to refine and test a digital intervention named WAYPOINT to help patients monitor and manage symptoms after CAR-T therapy.

    Trial name
    APPROACH (NCT07886190)
    Testing
    WAYPOINT
    Where
    United States
    Volunteers
    65 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? APPROACH
  • Depression - Major Depressive Disorder

    Effect of Neurofeedback and TMS

    • Not yet recruiting
    • Age: 18 to 65 years
    • Medical device

    The goal of this clinical trial is to is to learn whether adding EEG neurofeedback (NFB) to repetitive transcranial magnetic stimulation (rTMS) is safe and feasible for adults with major depressive disorder (MDD).

    Trial name
    NCT07892287
    Testing
    Repetitive Transcranial Magnetic Stimulation, Alpha-down EEG Neurofeedback
    Volunteers
    20 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? NCT07892287
  • HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD)

    Reducing Arterial Inflammation Using Eplerenone and Statins in HIV

    • Not yet recruiting
    • Age: 40 to 80 years
    • Phase 2/3

    HIV has transitioned to a chronic disease in which well-treated persons remain at higher risk for heart disease when compared to the general population.

    Conditions
    HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD), Arterial Inflammation, Heart Disease
    Trial name
    SUNRISE HIV (NCT07892664)
    Testing
    Eplerenone
    Where
    2 sites in United States
    Volunteers
    124 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? SUNRISE HIV
  • Lymphoma, B-cell Lymphomas

    GLORY: Glofit-GemOx With Liso-Cel For Lymphoma

    • Recruiting
    • Age: 18 years and older
    • Phase 2
    • Surgery or procedure

    The goal of this clinical trial is to assess the clinical efficacy of bridging therapy with glofitamab/gemcitabine/oxaliplatin (Glofit-GemOx) followed by lisocabtagene maraleucel (liso-cel) in relapsed/refractory large B-cell…

    Conditions
    Lymphoma, B-cell Lymphomas, Relapsed/Refractory Large B-cell Lymphoma, Large B-cell Lymphoma
    Trial name
    GLORY (NCT07711483)
    Testing
    Obinutuzumab, Glofitamab, Gemcitabine & oxaliplatin
    Where
    2 sites in United States
    Volunteers
    56 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? GLORY
  • Prostate Cancer

    Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy

    • Recruiting
    • Age: 18 years and older
    • Observational study

    This study will evaluate a method to detect tumor cells that are circulating in the blood without getting a biopsy. The investigators already know from other studies that cancer tumors shed a small number of cells into the…

    Trial name
    NCT01961713
    Where
    United States
    Volunteers
    200 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? NCT01961713

Completed, with results posted

All 696
  • Hodgkin Lymphoma

    Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma

    • Completed
    • Age: 18 years and older
    • Phase 2
    • Results posted

    Limited stage Hodgkin lymphoma is a highly curable disease, but standard treatment with ABVD chemotherapy and radiation can lead to late risks of secondary cancers, lung injury, heart injury, and others.

    Trial name
    NCT02505269
    Testing
    Brentuximab Vedotin, Adriamycin, Dacarbazine
    Where
    2 sites in United States
    Volunteers
    34 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? NCT02505269
  • Emergencies

    Video Images About Decisions for Ethical Outcomes in the Emergency Department (VIDEO-ED)

    • Completed
    • Age: 50 years and older
    • Lifestyle or therapy programme
    • Results posted

    A randomized controlled trial of a video decision aid in the Emergency Department Setting to improve advance care planning documentation.

    Trial name
    VIDEO-ED (NCT04931797)
    Testing
    video decision aid, control arm ACP information sheet
    Where
    4 sites in United States
    Volunteers
    598 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? VIDEO-ED
  • Electronic Cigarette Use

    Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC

    • Completed
    • Age: 18 years and older
    • Medical device
    • Results posted

    The goal of this study is to conduct a pilot randomized waitlist-controlled trial to assess the feasibility, acceptability, and preliminary effects of substituting the NIDA standardized research e-cigarette (SREC) for combusted…

    Trial name
    SWITCHED (NCT05881304)
    Testing
    Standardized research e-cigarette (SREC)
    Where
    United States
    Volunteers
    41 people, healthy volunteers welcome
    Sponsor
    Massachusetts General Hospital
    Can I take part? SWITCHED
  • Lymphoma, B-Cell, Relapsed Cancer

    Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

    • Completed
    • Age: 18 years and older
    • Surgery or procedure
    • Results posted

    Participants are invited to take part in this research study because they have relapsed (cancer has come back) or refractory (cancer has not responded to treatment) B-cell Lymphoma and will be undergoing CAR T-cell Therapy.

    Conditions
    Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma, Diffuse Large B Cell Lymphoma
    Trial name
    NCT06004167
    Testing
    Adaptive Bridging Radiation Therapy (ABRT)
    Where
    2 sites in United States
    Volunteers
    10 people
    Sponsor
    Massachusetts General Hospital
    Can I take part? NCT06004167
  • Pregnancy Related, Burnout, Professional

    The 4th Trimester Initiative: The Impact of Parental Support on Pregnant Trainee Wellbeing

    • Completed
    • Age: All ages
    • Medical device
    • Lifestyle or therapy programme
    • Results posted

    The goal of this clinical trial is to determine the impact of a parental support package for new trainee mothers which focuses on mentorship, lactation, and sleep, and access to perinatal care.

    Conditions
    Pregnancy Related, Burnout, Professional, Wellness, Psychological
    Trial name
    NCT06014892
    Testing
    Snoo smart bassinet, Willow wearable breast pump, Maven Clinic on-demand perinatal consultation
    Where
    7 sites in United States
    Volunteers
    156 people, healthy volunteers welcome
    Sponsor
    Massachusetts General Hospital
    Can I take part? NCT06014892

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in